n-acetyl-s-(1,2-dichlorovinyl)-l-cysteine
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Feb 1, 2012 (NCT02105675)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dcvac
- dcvac
- dcvac
- n-acetyl(1,2-dichloroviny)cysteine
- n-acetyl-dcvc
- n-acetyl-s-(1,2-dichlorovinyl)-l-cysteine
- s-1,2-dichlorovinyl-n-acetylcysteine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02111577 | Phase 3 | Apr 1, 2014 | Accord Research |
| NCT02107391 | Phase 2 | Mar 1, 2012 | Accord Research |
| NCT02105675 | Phase 2 | Feb 1, 2012 | Accord Research |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Accord Research | For profit | 3 | 3 | 2 | 2012 |
1 organizations
Page 1 / 1